Is serum uric acid level associated with all-cause mortality in high-functioning older persons: MacArthur studies of

P Hu1, T E Seeman, T B Harris

  • 1Multicampus Program in Geriatric Medicine and Gerontology, UCLA School of Medicine, 90095, USA.

Insights

High serum uric acid levels do not independently predict mortality in healthy older adults. Inflammation and other factors are important confounders in this association.

Area of Science:

  • Gerontology
  • Epidemiology
  • Biochemistry

Background:

  • Controversy exists regarding serum uric acid's role as an independent risk factor for mortality.
  • The predictive value of uric acid levels for mortality in older populations is not well-established.

Purpose of the Study:

  • To investigate the association between serum uric acid levels and all-cause mortality in high-functioning, community-dwelling older individuals.
  • To determine if serum uric acid is an independent predictor of mortality in this demographic.

Main Methods:

  • Prospective cohort study design involving 870 participants from the MacArthur Studies of Successful Aging.
  • Baseline measurements included serum uric acid, C-reactive protein (CRP), and interleukin-6 (IL-6).
  • Logistic regression analyses were employed to assess the relationship between uric acid levels and 7-year all-cause mortality, adjusting for confounders.

Main Results:

  • In men, elevated serum uric acid levels showed no significant association with increased 7-year total mortality.
  • In women, higher serum uric acid levels were associated with a trend towards decreased mortality.
  • C-reactive protein (CRP) and interleukin-6 (IL-6) were identified as significant confounders.

Conclusions:

  • Serum uric acid level is not an independent predictor of increased total mortality in high-functioning older adults.
  • Inflammation and other underlying risk factors must be considered when assessing the relationship between serum uric acid and mortality.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.